Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells.

Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells. Abstract Text:

    michael j macdonaldMichael J MacDonald,

    Insulin secretion by the beta cell depends on anaplerosis in which insulin secretagogues are metabolized by mitochondria into molecules that are most likely exported to the extramitochondrial space where they have signaling roles. However, very little is known about the products of anaplerosis. We discovered an experimental paradigm that has begun to provide new information about these products. When various intracellular metabolites were applied in combination to overnight-cultured rat or human pancreatic islets or to INS-1 832/13 cells, they interacted synergistically to strongly stimulate insulin release. When these same metabolites were applied individually to these cells, insulin stimulation was poor. Discerning the contributions of the individual compounds to metabolism has begun to allow us to dissect some of the pathways involved in insulin secretion, which was not possible from studying individual secretagogues. Monomethyl succinate (MMS) combined with a barely stimulatory concentration of alpha-ketoisocaproate (KIC) (2 mm) stimulated insulin release in cultured rat islets 18-fold (versus 21-fold for 16.7 mm glucose). MMS plus low glucose (2 mm) or pyruvate (5 mm) gave 11- and 9-fold stimulations. These agents also potentiated MMS-induced insulin release in fresh islets, and KIC plus MMS gave synergistic insulin release in cultured human islets. In INS-1 cells, neither MMS nor KIC (10 mm) was an insulin secretagogue, but when added together KIC (2 mm) and MMS stimulated insulin release 7-fold (versus 12-fold for glucose). In islets and INS-1 cells, conditions that stimulated insulin release caused large relative increases in acetoacetate, which is a precursor of pathways to short chain acyl-CoAs. Liquid chromatography-tandem mass spectrometry measurements of acetyl-CoA, acetoacetyl-CoA, succinyl-CoA, hydroxymethylglutaryl-CoA, and malonyl-CoA confirmed that they were increased by insulin secretagogues. The results suggest a new mechanism of insulin secretion in which anaplerosis increases short chain acyl-CoAs that have roles in insulin exocytosis.

    Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells. Publishing Authors By Initials

    mj macdonaldMJ MacDonald,

    For similar animals: chordata: vertebrates: mammals: rodentia: muridae: murinae: rats: rats, sprague-dawley research abstracts see: animals: chordata: vertebrates: mammals: rodentia: muridae: murinae: rats: rats, sprague-dawley research

    PUBMED ID PMID:

    MEDLINE DATE:

    Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Journal of biological chemistry

    VOLUME: 282

    Page Numbers: 6043-52

    Journal Abbreviation: J. Biol. Chem.

    ISSN: 0021-9258

    DAY: 8

    MONTH: 01

    YEAR: 2007

    Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2985121

    Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells. Keywords Mesh Terms:

    KEYWORDS: Rats, Sprague-Dawley

    MESH TERMS: secretion

    Chemical & Substance for Abstract: Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells. Information

    Substance Name: acetoacetic acid

    Registry Number: 541-50-4

    Grant and Affiliation Information for Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells.

    AFFILIATION: Childrens Diabetes Center, University of Wisconsin Medical School, Madison, Wisconsin 53706, USA. mjmacdon@wisc.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDDK

    GRANT: DK28348

    ACRONYM: DK

    MEDLINETA: J Biol Chem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News